BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 12383381)

  • 21. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
    Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose intra-arterial urokinase and aggressive mechanical clot disruption for acute ischemic stroke after failure of intravenous thrombolysis.
    Yoon W; Park MS; Cho KH
    AJNR Am J Neuroradiol; 2010 Jan; 31(1):161-4. PubMed ID: 19713319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography--guided pilot study.
    Sekoranja L; Loulidi J; Yilmaz H; Lovblad K; Temperli P; Comelli M; Sztajzel RF
    Stroke; 2006 Jul; 37(7):1805-9. PubMed ID: 16763175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke.
    Menon BK; Al-Ajlan FS; Najm M; Puig J; Castellanos M; Dowlatshahi D; Calleja A; Sohn SI; Ahn SH; Poppe A; Mikulik R; Asdaghi N; Field TS; Jin A; Asil T; Boulanger JM; Smith EE; Coutts SB; Barber PA; Bal S; Subramanian S; Mishra S; Trivedi A; Dey S; Eesa M; Sajobi T; Goyal M; Hill MD; Demchuk AM;
    JAMA; 2018 Sep; 320(10):1017-1026. PubMed ID: 30208455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis.
    Abou-Chebl A; Bajzer CT; Krieger DW; Furlan AJ; Yadav JS
    Stroke; 2005 Oct; 36(10):2286-8. PubMed ID: 16179581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
    Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
    Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized comparison of intra-arterial and intravenous thrombolysis in a canine model of acute basilar artery thrombosis.
    Qureshi AI; Boulos AS; Hanel RA; Suri MF; Yahia AM; Alberico RA; Hopkins LN
    Neuroradiology; 2004 Dec; 46(12):988-95. PubMed ID: 15580491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous glycoprotein IIb/IIIa inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke.
    Mangiafico S; Cellerini M; Nencini P; Gensini G; Inzitari D
    AJNR Am J Neuroradiol; 2005; 26(10):2595-601. PubMed ID: 16286408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review of outcome after ischemic stroke due to anterior circulation occlusion treated with intravenous, intra-arterial, or combined intravenous+intra-arterial thrombolysis.
    Mullen MT; Pisapia JM; Tilwa S; Messé SR; Stein SC
    Stroke; 2012 Sep; 43(9):2350-5. PubMed ID: 22811451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombus burden is associated with clinical outcome after intra-arterial therapy for acute ischemic stroke.
    Barreto AD; Albright KC; Hallevi H; Grotta JC; Noser EA; Khaja AM; Shaltoni HM; Gonzales NR; Illoh K; Martin-Schild S; Campbell MS; Weir RU; Savitz SI
    Stroke; 2008 Dec; 39(12):3231-5. PubMed ID: 18772444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA).
    Campbell BC; Mitchell PJ; Yan B; Parsons MW; Christensen S; Churilov L; Dowling RJ; Dewey H; Brooks M; Miteff F; Levi C; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Kleinig T; Scroop R; Chryssidis S; Barber A; Hope A; Moriarty M; McGuinness B; Wong AA; Coulthard A; Wijeratne T; Lee A; Jannes J; Leyden J; Phan TG; Chong W; Holt ME; Chandra RV; Bladin CF; Badve M; Rice H; de Villiers L; Ma H; Desmond PM; Donnan GA; Davis SM;
    Int J Stroke; 2014 Jan; 9(1):126-32. PubMed ID: 24207098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New grading system for angiographic evaluation of arterial occlusions and recanalization response to intra-arterial thrombolysis in acute ischemic stroke.
    Qureshi AI
    Neurosurgery; 2002 Jun; 50(6):1405-14; discussion 1414-5. PubMed ID: 12015866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postprocedure intravenous eptifibatide following intra-arterial reteplase in patients with acute ischemic stroke.
    Qureshi AI; Hussein HM; Janjua N; Harris-Lane P; Ezzeddine MA
    J Neuroimaging; 2008 Jan; 18(1):50-5. PubMed ID: 18190496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
    Shaltoni HM; Albright KC; Gonzales NR; Weir RU; Khaja AM; Sugg RM; Campbell MS; Cacayorin ED; Grotta JC; Noser EA
    Stroke; 2007 Jan; 38(1):80-4. PubMed ID: 17122433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion.
    Straub S; Junghans U; Jovanovic V; Wittsack HJ; Seitz RJ; Siebler M
    Stroke; 2004 Mar; 35(3):705-9. PubMed ID: 14752128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-pressure balloon angioplasty with adjuvant pharmacological therapy in patients with acute ischemic stroke caused by intracranial arterial occlusions.
    Nogueira RG; Schwamm LH; Buonanno FS; Koroshetz WJ; Yoo AJ; Rabinov JD; Pryor JC; Hirsch JA
    Neuroradiology; 2008 Apr; 50(4):331-40. PubMed ID: 18172631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study.
    Rubiera M; Ribo M; Pagola J; Coscojuela P; Rodriguez-Luna D; Maisterra O; Ibarra B; Piñeiro S; Meler P; Romero FJ; Alvarez-Sabin J; Molina CA
    Stroke; 2011 Apr; 42(4):993-7. PubMed ID: 21372307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new therapeutic strategy for acute ischemic stroke: sequential combined intravenous tPA-tenecteplase for proximal middle cerebral artery occlusion based on first results in 13 consecutive patients.
    Smadja D; Chausson N; Joux J; Saint-Vil M; Signaté A; Edimonana M; Jeannin S; Bartoli B; Aveillan M; Cabre P; Olindo S
    Stroke; 2011 Jun; 42(6):1644-7. PubMed ID: 21527758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buying time for recanalization in acute stroke: arterial blood infusion beyond the occluding clot as a neuroprotective strategy.
    Ribó M; Molina C; Alvarez B; Dinia L; Alvarez-Sabin J; Matas M
    J Neuroimaging; 2009 Apr; 19(2):188-90. PubMed ID: 18800999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.